USDM was able to deliver DocuSign, fully validated and compliant, for a BioPharma customer, to enable e-signature functionality for employees now working remotely due to COVID-19.
The customer, Autolus, was able to be up and running in just seven days and maintain business continuity. Further, the complete validation documentation and maintenance of software changes through a Cloud Assurance subscription set Autolus up for future growth and scalability to expand into new use cases while staying in a continuously compliant state.
Transitioning an entire life sciences organization to be able to support working from home during the COVID-19 pandemic can be daunting. USDM can help.
- Autolus, a biopharma company at the forefront of cancer treatments
- The company needed a fast solution for e-signature capabilities due to the COVID-19 remote working mandate
- Stakeholders included IT, QA, and the Business System Owner